COMMUNIQUÉS West-GlobeNewswire

DoseSpot Collaborates with Amazon Pharmacy to Improve Prescription Medication Pricing Transparency, Give Patients More Fulfillment Options
22/07/2025
Companies share a commitment to helping patients get the medications they need quickly, affordably, and with price transparency BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- DoseSpot , which delivers best-in-class e- [...]
American Gene Technologies Announces Promising Results from AGT103-T HIV Functional Cure Program Presented as Late-Breaker at International AIDS Society 2025
22/07/2025
All evaluable patients (n=5), demonstrated a significant reduction in Intact Proviral HIV DNA (IPDA) following treatment with AGT103-T ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT [...]
100,000 Customers Choose Hemp Hop As Their Go-To Place to Buy THCa Flower
22/07/2025
CHARLOTTE, N.C., July 22, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has now served over 100,000 unique customers, marking a major milestone for the family owned hemp brand. Based in Charlotte, North Carolina, Hemp Hop has grown [...]
HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder
22/07/2025
Study Initiation Marks Key Milestone in Advancing Precision Psychiatry Treatment for Major Depressive Disorder Topline Results Anticipated in the First Half of 2026 MUNICH, Germany and SOUTH SAN FRANCISCO, Calif., July [...]
Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention
22/07/2025
New Taipei City, Taiwan, July 22, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and [...]
Instinct EMR Partners with Arista Advanced Pet Care’s New Specialty and Emergency Hospitals
22/07/2025
PHILADELPHIA, July 22, 2025 (GLOBE NEWSWIRE) -- Instinct Science, a veterinary software company known for its medically sophisticated cloud-based tools, announced an ongoing partnership with Arista Advanced Pet Care, a [...]
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
22/07/2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 22 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 29 - 2025
22/07/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 14 juillet au 18 juillet 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2025
22/07/2025
Aggregated presentation by day and by market Statement of transactions in own shares from July 14th to July 18th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)
22/07/2025
TORONTO, July 22, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the investigator-led Phase II trial titled “ P revention O f N ephro T [...]
BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET
22/07/2025
PALO ALTO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it [...]
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
22/07/2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
Reunion Neuroscience Announces Publication of RE104 Phase 1 Data in The Journal of Clinical Psychopharmacology
22/07/2025
-- Phase 1 Data Highlight RE104 Favorable Safety Profile and Short Duration Psychoactive Experience -- -- Topline Results from RECONNECT Phase 2 Trial of RE104 in Postpartum Depression (PPD) Anticipated in Q3 2025 -- [...]
Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.
22/07/2025
GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification
22/07/2025
Tel Aviv, July 22, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and [...]
NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025
22/07/2025
– NewAmsterdam to host conference call at 10:00 a.m. ET on Wednesday, July 30th – NAARDEN, the Netherlands and MIAMI, July 22, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or [...]
Survivor Healthcare Announces the Appointment of Catherine Cowan as Senior Vice President of Clinical Operations
22/07/2025
Cowan will oversee clinical strategy, quality improvement, and expansion of multidisciplinary care teams Appointment strengthens Survivor Healthcare’s mission to deliver integrated, high-quality primary care to cancer [...]
Hydreight to Participate in the Canaccord Genuity 45th Annual Growth Conference in Boston
22/07/2025
VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS | OTCQB: HYDTF | FSE: SO6) (“Hydreight” or the “Company”), a telehealth and mobile medical company operating across [...]
Daxor’s Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions
22/07/2025
Continued Integration of Daxor’s ezBVA Lab Service and On-Site Analyzers Fuels Positive Outlook Oak Ridge, TN, July 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume [...]

Pages